Florida Senate - 2009 SENATOR AMENDMENT
Bill No. CS for CS for SB 1840
Barcode 872678
LEGISLATIVE ACTION
Senate . House
.
.
.
Floor: 5/WD/2R .
04/16/2009 03:18 PM .
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
Senators Deutch and Rich moved the following:
1 Senate Amendment (with title amendment)
2
3 Delete lines 197 - 199
4 and insert:
5 (9) Revenue generated from the surcharge levied under this
6 section shall be deposited into the Health Care Trust Fund
7 within the Agency for Health Care Administration, except as
8 otherwise directed in this section.
9 (10) Beginning in the 2009-2010 fiscal year and each fiscal
10 year thereafter, the equivalent of the first 15 percent of the
11 revenue generated from the surcharge levied under this section,
12 prior to the computation of the trust fund surcharge imposed by
13 s. 215.20, shall be allocated to biomedical research conducted
14 within this state as follows:
15 (a) The sum of 5.8445 percent of the revenue generated from
16 the surcharge levied in this section to the H. Lee Moffitt
17 Cancer Center and Research Institute, established in s. 1004.43,
18 which shall be paid monthly to the center’s board of directors
19 by warrant drawn by the Chief Financial Officer upon the State
20 Treasury. The revenues derived from this allocation are separate
21 and distinct from any funds allocated to the H. Lee Moffitt
22 Cancer Center through the James and Esther King Biomedical
23 Research Program or the William G. “Bill” Bankhead, Jr., and
24 David Coley Cancer Research Program. Funds derived pursuant to
25 this paragraph shall be used for the purpose of constructing,
26 furnishing, and equipping cancer research, treatment, and
27 related facilities, and, at the discretion of the board of
28 directors, for matters in furtherance of the mission of the
29 cancer center or institute. Moneys transferred to the board of
30 directors of the H. Lee Moffitt Cancer and Research Institute
31 pursuant to s. 210.011 may be used to pay or secure bonds or
32 financial products issued or incurred in connection with the
33 financing of costs related to constructing, furnishing, and
34 equipping the cancer research, treatment, and related
35 facilities. Such financing may include the issuance of tax
36 exempt bonds or other forms of indebtedness by a local
37 authority, municipality, or county pursuant to parts II and III
38 of chapter 159. Such bonds shall not constitute state bonds for
39 purposes of s. 11, Art. VII of the State Constitution, but shall
40 constitute bonds of a local agency, as defined in s. 159.27(4).
41 (b) The sum of 1.7534 percent of the revenue generated from
42 the surcharge levied in this section to the University of
43 Florida Shands Cancer Center. The revenues derived from this
44 allocation are separate and distinct from any funds allocated to
45 the University of Florida Shands Cancer Center through the James
46 and Esther King Biomedical Research Program or the William G.
47 “Bill” Bankhead, Jr., and David Coley Cancer Research Program.
48 Funds derived pursuant to this paragraph shall be used for the
49 purposes of constructing, furnishing, and equipping cancer
50 research, treatment, and related facilities, and may include the
51 recruitment and retention of faculty or other personnel related
52 to research programs.
53 (c) The sum of 1.7534 percent of the revenue generated from
54 the surcharge levied in this section to the Sylvester
55 Comprehensive Cancer Center at the University of Miami Miller
56 School of Medicine. The revenues derived from this allocation
57 are separate and distinct from any funds allocated to the
58 Sylvester Comprehensive Cancer Center at the University of Miami
59 Miller School of Medicine through the James and Esther King
60 Biomedical Research Program or the William G. “Bill” Bankhead,
61 Jr., and David Coley Cancer Research Program. Funds derived
62 pursuant to this paragraph shall be used for the purposes of
63 constructing, furnishing, and equipping cancer research,
64 treatment, and related facilities, and may include the
65 recruitment and retention of faculty or other personnel related
66 to research programs.
67 (d) The sum of 5.1812 percent of the revenue generated from
68 the surcharge levied in this section to the Biomedical Research
69 Trust Fund for distribution by the Biomedical Research Advisory
70 Council to grantees of the James and Esther King Biomedical
71 Research Program and the William G. “Bill” Bankhead, Jr., and
72 David Coley Cancer Research Program. The programs shall equally
73 divide the allocation, subject to the methods provided in ss.
74 215.5602 and 381.922, respectively.
75 (e) The sum of 0.2922 percent of the revenue generated from
76 the surcharge levied in this section to the Biomedical Research
77 Trust Fund for distribution to the Diabetes Research Institute
78 for the purposes of conducting research.
79 (f) The sum of 0.1753 percent of the revenue generated from
80 the surcharge levied in this section to the Biomedical Research
81 Trust Fund for distribution to the Miami Project to Cure
82 Paralysis for the purposes of conducting research.
83
84 ================= T I T L E A M E N D M E N T ================
85 And the title is amended as follows:
86 Delete line 17
87 and insert:
88 Care Administration; providing for the allocation of
89 revenue generated from the cigarette surcharge;
90 amending s. 210.04, F.S., to